Babson Diagnostics’ Eric Olson Outlines Company’s Innovative Blood Draw Model

Nov. 21, 2022, issue also explores a five-step process for implementing a new LIS

Healthcare technology company Babson Diagnostics is pursuing a new hybrid model for blood draws that it believes brings together the best of clinical laboratories and retail pharmacies, and founder and COO Eric Olson explains the innovations unfolding at his company in an exclusive interview with The Dark Report.

Olson explains how Babson intends to be at the intersection of two trends: One bringing specimen collection services closer to the growing number of customers who are moving from conventional patient service centers  operated by clinical laboratories to alternative collection sites, particularly retail pharmacies; and the other, using technology to create a new collection method that is friendlier to patients, requires much smaller quantities of samples, and can be used by labs to deliver accurate, reproducible results using most existing analyzers.

Elsewhere in the issue, The Dark Report:

  • Reports on how the VALID and SALSA Acts are still pending in Congress, and that a third bill is proposed that would protect pathologist payments.
  • Outlines a five-step process for implementing a new laboratory information systems at a clinical lab.
  • Reviews how a Florida hospital laboratory team prepared before Hurricane Ian.
  • Notes that a lab allegedly billed Medicare for tests it did not perform, in what has characteristics of a pass-through billing scheme.

All of these intelligence briefings and more are available to subscribers of The Dark Report. If you’re not a subscriber, try our free, 14-day trial.